PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial

F Lordick; K Ott; BDJ Krause; WA Weber; K Becker; Hubert Stein; S Lorenzen; T Schuster; H Wieder; K Herrmann; R Bredenkamp; H Hofler; U Fink; C Peschel; M Schwaiger; JR Siewert

doi:10.1016/S1470-2045(07)70244-9

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial

F Lordick
, K Ott
, BDJ Krause
, WA Weber
, K Becker
, Hubert Stein
, S Lorenzen
, T Schuster
, H Wieder
, K Herrmann
, R Bredenkamp
, H Hofler
, U Fink
, C Peschel
, M Schwaiger
, JR Siewert

Department of Surgery

Research output: Contribution to journal › Original Article › peer-review

629 Citations (Web of Science)

Original language	English
Pages (from-to)	797-805
Journal	LANCET ONCOL
Volume	8
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(07)70244-9
Publication status	Published - 2007

Keywords

POSITRON-EMISSION-TOMOGRAPHY
SQUAMOUS-CELL CARCINOMA
ADVANCED ESOPHAGEAL CANCER
PREOPERATIVE CHEMOTHERAPY
NEOADJUVANT THERAPY
GASTRIC-CARCINOMA
TUMOR RESPONSE
F-18-FDG PET
FDG-PET
SURGERY

Access to Document

10.1016/S1470-2045(07)70244-9

Cite this

Lordick, F., Ott, K., Krause, BDJ., Weber, WA., Becker, K., Stein, H., Lorenzen, S., Schuster, T., Wieder, H., Herrmann, K., Bredenkamp, R., Hofler, H., Fink, U., Peschel, C., Schwaiger, M., & Siewert, JR. (2007). PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial. LANCET ONCOL, 8(9), 797-805. https://doi.org/10.1016/S1470-2045(07)70244-9

@article{d47a2fb8bcec4f338f33f16f8475feec,

title = "PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, SQUAMOUS-CELL CARCINOMA, ADVANCED ESOPHAGEAL CANCER, PREOPERATIVE CHEMOTHERAPY, NEOADJUVANT THERAPY, GASTRIC-CARCINOMA, TUMOR RESPONSE, F-18-FDG PET, FDG-PET, SURGERY",

author = "F Lordick and K Ott and BDJ Krause and WA Weber and K Becker and Hubert Stein and S Lorenzen and T Schuster and H Wieder and K Herrmann and R Bredenkamp and H Hofler and U Fink and C Peschel and M Schwaiger and JR Siewert",

note = "Stein: Department of Surgery, Paracelsus Private Medical University, Salzburg, Austria",

year = "2007",

doi = "10.1016/S1470-2045(07)70244-9",

language = "English",

volume = "8",

pages = "797--805",

journal = "LANCET ONCOL",

issn = "1470-2045",

publisher = "Elsevier ",

number = "9",

}

Lordick, F, Ott, K, Krause, BDJ, Weber, WA, Becker, K, Stein, H, Lorenzen, S, Schuster, T, Wieder, H, Herrmann, K, Bredenkamp, R, Hofler, H, Fink, U, Peschel, C, Schwaiger, M & Siewert, JR 2007, 'PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial', LANCET ONCOL, vol. 8, no. 9, pp. 797-805. https://doi.org/10.1016/S1470-2045(07)70244-9

TY - JOUR

T1 - PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial

AU - Lordick, F

AU - Ott, K

AU - Krause, BDJ

AU - Weber, WA

AU - Becker, K

AU - Stein, Hubert

AU - Lorenzen, S

AU - Schuster, T

AU - Wieder, H

AU - Herrmann, K

AU - Bredenkamp, R

AU - Hofler, H

AU - Fink, U

AU - Peschel, C

AU - Schwaiger, M

AU - Siewert, JR

N1 - Stein: Department of Surgery, Paracelsus Private Medical University, Salzburg, Austria

PY - 2007

Y1 - 2007

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - SQUAMOUS-CELL CARCINOMA

KW - ADVANCED ESOPHAGEAL CANCER

KW - PREOPERATIVE CHEMOTHERAPY

KW - NEOADJUVANT THERAPY

KW - GASTRIC-CARCINOMA

KW - TUMOR RESPONSE

KW - F-18-FDG PET

KW - FDG-PET

KW - SURGERY

U2 - 10.1016/S1470-2045(07)70244-9

DO - 10.1016/S1470-2045(07)70244-9

M3 - Original Article

SN - 1470-2045

VL - 8

SP - 797

EP - 805

JO - LANCET ONCOL

JF - LANCET ONCOL

IS - 9

ER -